THOMAS DUST: Open Payments
NPI 1477984656 · MATTOON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,001 in 87 payments from 26 companies in 2025. Trend: 2023 $151 · 2024 $74 · 2025 $2,001
Food & beverage: $1,505Education: $496
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $309 |
| Novartis Pharmaceuticals Corporation | 15 | $225 |
| AstraZeneca Pharmaceuticals LP | 10 | $223 |
| SEAGEN INC. | 2 | $198 |
| Lilly USA, LLC | 7 | $170 |
| Merck Sharp & Dohme LLC | 7 | $155 |
| Daiichi Sankyo Inc. | 3 | $81 |
| Regeneron Healthcare Solutions, Inc. | 3 | $79 |
| ABBVIE INC. | 3 | $72 |
| Incyte Corporation | 3 | $62 |
Products named: KEYTRUDA, RYBREVANT, ENHERTU, KISQALI, DARZALEX, Fabhalta, LIBTAYO, LYNPARZA.
Industry payments across IL — which companies pay providers there.
